annual operating expenses:
$17.05B+$3.42B(+25.06%)Summary
- As of today (May 29, 2025), NVO annual total operating expenses is $17.05 billion, with the most recent change of +$3.42 billion (+25.06%) on December 31, 2024.
- During the last 3 years, NVO annual operating expenses has risen by +$7.75 billion (+83.21%).
- NVO annual operating expenses is now at all-time high.
Performance
NVO Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$3.72B-$1.41B(-27.47%)Summary
- As of today (May 29, 2025), NVO quarterly total operating expenses is $3.72 billion, with the most recent change of -$1.41 billion (-27.47%) on March 31, 2025.
- Over the past year, NVO quarterly operating expenses has increased by +$287.20 million (+8.36%).
- NVO quarterly operating expenses is now -27.47% below its all-time high of $5.13 billion, reached on December 31, 2024.
Performance
NVO quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
NVO Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +25.1% | +8.4% |
| 3 y3 years | +83.2% | +54.6% |
| 5 y5 years | +130.0% | +106.9% |
NVO Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +83.2% | -27.5% | +54.7% |
| 5 y | 5-year | at high | +130.0% | -27.5% | +121.2% |
| alltime | all time | at high | >+9999.0% | -27.5% | +2552.9% |
NVO Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $3.72B(-27.5%) |
| Dec 2024 | $17.05B(+25.1%) | $5.13B(+33.0%) |
| Sep 2024 | - | $3.86B(-16.1%) |
| Jun 2024 | - | $4.60B(+33.8%) |
| Mar 2024 | - | $3.44B(-18.1%) |
| Dec 2023 | $13.64B(+30.5%) | $4.20B(+30.0%) |
| Sep 2023 | - | $3.23B(-2.1%) |
| Jun 2023 | - | $3.30B(+13.3%) |
| Mar 2023 | - | $2.91B(-6.9%) |
| Dec 2022 | $10.45B(+12.2%) | $3.13B(+27.0%) |
| Sep 2022 | - | $2.46B(+2.3%) |
| Jun 2022 | - | $2.41B(-0.1%) |
| Mar 2022 | - | $2.41B(-15.2%) |
| Dec 2021 | $9.31B(+17.1%) | $2.84B(+25.1%) |
| Sep 2021 | - | $2.27B(+10.1%) |
| Jun 2021 | - | $2.06B(-2.3%) |
| Mar 2021 | - | $2.11B(-14.2%) |
| Dec 2020 | $7.95B(+7.2%) | $2.46B(+20.7%) |
| Sep 2020 | - | $2.04B(+21.0%) |
| Jun 2020 | - | $1.68B(-6.5%) |
| Mar 2020 | - | $1.80B(-19.7%) |
| Dec 2019 | $7.41B(-0.3%) | $2.24B(+22.4%) |
| Sep 2019 | - | $1.83B(+3.6%) |
| Jun 2019 | - | $1.77B(+12.4%) |
| Mar 2019 | - | $1.57B(-28.1%) |
| Dec 2018 | $7.44B(+8.4%) | $2.19B(+21.5%) |
| Sep 2018 | - | $1.80B(+3.4%) |
| Jun 2018 | - | $1.74B(+2.5%) |
| Mar 2018 | - | $1.70B(-19.0%) |
| Dec 2017 | $6.86B(+0.0%) | $2.10B(+28.8%) |
| Sep 2017 | - | $1.63B(+1.5%) |
| Jun 2017 | - | $1.60B(+4.5%) |
| Mar 2017 | - | $1.53B(-21.3%) |
| Dec 2016 | $6.86B(+9.1%) | $1.95B(+16.8%) |
| Sep 2016 | - | $1.67B(+0.7%) |
| Jun 2016 | - | $1.66B(+5.1%) |
| Mar 2016 | - | $1.58B(-18.2%) |
| Dec 2015 | $6.29B(-11.3%) | $1.93B(+18.0%) |
| Sep 2015 | - | $1.63B(+2.9%) |
| Jun 2015 | - | $1.59B(+40.3%) |
| Mar 2015 | - | $1.13B(-41.0%) |
| Dec 2014 | $7.09B(+5.0%) | $1.92B(+5.2%) |
| Sep 2014 | - | $1.82B(+7.6%) |
| Jun 2014 | - | $1.70B(+4.4%) |
| Mar 2014 | - | $1.62B(-18.7%) |
| Dec 2013 | $6.76B(+11.5%) | $2.00B(+24.9%) |
| Sep 2013 | - | $1.60B(-0.7%) |
| Jun 2013 | - | $1.61B(+3.2%) |
| Mar 2013 | - | $1.56B(-12.4%) |
| Dec 2012 | $6.06B(+3.4%) | $1.78B(+24.8%) |
| Sep 2012 | - | $1.43B(-1.6%) |
| Jun 2012 | - | $1.45B(+3.2%) |
| Mar 2012 | - | $1.40B(-9.5%) |
| Dec 2011 | $5.86B | $1.55B(+5.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2011 | - | $1.47B(+0.1%) |
| Jun 2011 | - | $1.47B(+10.0%) |
| Mar 2011 | - | $1.34B(-15.3%) |
| Dec 2010 | $5.38B(+13.3%) | $1.58B(+21.4%) |
| Sep 2010 | - | $1.30B(+3.4%) |
| Jun 2010 | - | $1.26B(-0.6%) |
| Mar 2010 | - | $1.27B(-1.1%) |
| Dec 2009 | $4.75B(+4.2%) | $1.28B(+9.8%) |
| Sep 2009 | - | $1.17B(+1.4%) |
| Jun 2009 | - | $1.15B(+6.5%) |
| Mar 2009 | - | $1.08B(-8.9%) |
| Dec 2008 | $4.56B(+7.1%) | $1.19B(+11.1%) |
| Sep 2008 | - | $1.07B(-10.6%) |
| Jun 2008 | - | $1.20B(+10.8%) |
| Mar 2008 | - | $1.08B(-23.4%) |
| Dec 2007 | $4.25B(+26.0%) | $1.41B(+43.8%) |
| Sep 2007 | - | $980.12M(+0.4%) |
| Jun 2007 | - | $976.42M(+7.3%) |
| Mar 2007 | - | $909.60M(-9.3%) |
| Dec 2006 | $3.38B(+22.7%) | $1.00B(+23.7%) |
| Sep 2006 | - | $810.71M(-0.8%) |
| Jun 2006 | - | $816.89M(+9.0%) |
| Mar 2006 | - | $749.20M(-5.3%) |
| Dec 2005 | $2.75B(+16.7%) | $791.30M(+17.3%) |
| Sep 2005 | - | $674.82M(+7.2%) |
| Jun 2005 | - | $629.58M(-2.6%) |
| Mar 2005 | - | $646.34M(-8.4%) |
| Dec 2004 | $2.36B(+21.4%) | $705.23M(+20.2%) |
| Sep 2004 | - | $586.68M(+8.7%) |
| Jun 2004 | - | $539.86M(+1.3%) |
| Mar 2004 | - | $533.09M(-65.8%) |
| Dec 2003 | $1.94B(+21.5%) | $1.56B(+879.6%) |
| Sep 2003 | - | $158.89M(+3.7%) |
| Jun 2003 | - | $153.19M(+9.2%) |
| Mar 2003 | - | $140.33M |
| Dec 2002 | $1.60B(+9.4%) | - |
| Dec 2001 | $1.46B(-3.3%) | - |
| Dec 2000 | $1.51B(+6.5%) | - |
| Dec 1999 | $1.42B(+5.5%) | - |
| Dec 1998 | $1.35B(-10.7%) | - |
| Dec 1997 | $1.51B(-0.3%) | - |
| Dec 1996 | $1.51B(+5.6%) | - |
| Dec 1995 | $1.43B(+15.7%) | - |
| Dec 1994 | $1.24B(+67.0%) | - |
| Dec 1993 | $740.35M(-36.2%) | - |
| Dec 1992 | $1.16B(+103.8%) | - |
| Dec 1991 | $569.08M(+11.4%) | - |
| Dec 1990 | $510.97M(+33.0%) | - |
| Dec 1989 | $384.21M(+30.5%) | - |
| Dec 1988 | $294.33M(+12.3%) | - |
| Dec 1987 | $262.05M(+841.0%) | - |
| Dec 1986 | $27.85M(-78.3%) | - |
| Dec 1985 | $128.59M(+12.6%) | - |
| Dec 1984 | $114.18M | - |
FAQ
- What is Novo Nordisk A/S annual total operating expenses?
- What is the all time high annual operating expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S annual operating expenses year-on-year change?
- What is Novo Nordisk A/S quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Novo Nordisk A/S?
- What is Novo Nordisk A/S quarterly operating expenses year-on-year change?
What is Novo Nordisk A/S annual total operating expenses?
The current annual operating expenses of NVO is $17.05B
What is the all time high annual operating expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high annual total operating expenses is $17.05B
What is Novo Nordisk A/S annual operating expenses year-on-year change?
Over the past year, NVO annual total operating expenses has changed by +$3.42B (+25.06%)
What is Novo Nordisk A/S quarterly total operating expenses?
The current quarterly operating expenses of NVO is $3.72B
What is the all time high quarterly operating expenses for Novo Nordisk A/S?
Novo Nordisk A/S all-time high quarterly total operating expenses is $5.13B
What is Novo Nordisk A/S quarterly operating expenses year-on-year change?
Over the past year, NVO quarterly total operating expenses has changed by +$287.20M (+8.36%)